Pilot of a Trial Enrollment Diversity Dashboard

Launched by DANA-FARBER CANCER INSTITUTE · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new tool called the Trial Enrollment Diversity Dashboard (TEDD) to help ensure that people from different backgrounds are included in research studies for acute leukemia. The goal is to make sure that the trial participants reflect the diversity of patients who have this condition, which can lead to better and more effective treatments for everyone.

To be eligible for this study, you need to be at least 18 years old and have been diagnosed with leukemia, lymphoma, myeloma, or a related disease. You should also have seen a doctor for your condition at one of the study sites. If you are a medical professional, such as a physician or nurse practitioner, you can also participate if you treat adult patients with these diseases. If you join the study, you'll be helping to improve how future trials are conducted and may help researchers understand how to better serve all patients with leukemia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria Medical Professionals:
• • Physician, nurse practitioner, or physician assistant
• • -≥10% clinical effort (or one ½ day of clinic per week for those working \<1 FTE)
• • Treats adult patients with leukemia or related diseases at the study sites
• • Ability to understand and willingness to provide informed consent
• • Age 18 or older
• Inclusion Criteria Participant Population:
• • Age ≥18 years old
• • Diagnosis of leukemia, lymphoma, myeloma, or related diseases
• • Seen by a physician for this diagnosis at one of the study sites
• Exclusion Criteria Medical Professionals:
• • -Listed member of the research team
• Exclusion Criteria Participant Population:
• • -Participants without the diagnoses of interest listed above, participants not seen at the study sites.